Synthesis of structured lipids via acidolysis of docosahexaenoic acid single cell oil (DHASCO) with capric acid.
Screening of five commercially available lipases for the incorporation of capric acid (CA) into docosahexaenoic acid single cell oil (DHASCO) indicated that lipase PS-30 from Pseudomonas sp. was most effective. Of the various reaction parameters examined, namely, the mole ratio of substrates, enzyme amount, time of incubation, reaction temperature, and amount of added water, for CA incorporation into DHASCO, the optimum conditions were a mole ratio of 1:3 (DHASCO/CA) at a temperature of 45 degrees C, and a reaction time of 24 h in the presence of 4% enzyme and 2% water content. Examination of the positional distribution of fatty acids on the glycerol backbone of the modified DHASCO with CA showed that CA was present mainly in the sn-1,3 positions of the triacylglycerol (TAG) molecules. Meanwhile, DHA was favorably present in the sn-2 position, but also located in the sn-1 and sn-3 positions. The oxidative stability of the modified DHASCO in comparison with the original DHASCO, as indicated in the conjugated diene values, showed that the unmodified oil remained relatively unchanged during storage for 72 h, but DHASCO-based structured lipid was oxidized to a much higher level than the original oil. The modified oil also attained a considerably higher thiobarbituric acid reactive substances value than the original oil over the entire storage period. However, when the oil was subjected to the same process steps in the absence of any enzyme, there was no significant difference (p > 0.05) in its oxidative stability when compared with enzymatically modified DHASCO. Therefore, removal of antioxidants during the process is primarily responsible for the compromised stability of the modified oil.
Hamam
Fayez
F
Department of Biochemistry, Memorial University of Newfoundland, St. John's, Newfoundland, Canada A1B 3X9.
Shahidi
Fereidoon
F
D003652:Decanoic Acids / Q000378:metabolism*; D004281:Docosahexaenoic Acids / Q000378:metabolism*; D004355:Drug Stability; D005227:Fatty Acids / Q000032:analysis; D007700:Kinetics; D008049:Lipase / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis*; D010084:Oxidation-Reduction; D011549:Pseudomonas / Q000201:enzymology
D003652:Decanoic Acids; D005227:Fatty Acids; D008055:Lipids; D004281:Docosahexaenoic Acids; C031071:decanoic acid; D008049:Lipase